David Medical(SZ:300314) Xin Lang Cai Jing·2025-10-17 12:53Core Viewpoint - The company, David Medical, plans to use up to 400 million yuan of its own funds to engage in foreign exchange derivative trading to mitigate foreign exchange market risks and enhance capital efficiency [1]. Group 1: Trading Purpose and Amount - The primary objective of the trading is to reduce the impact of exchange rate fluctuations on the company's operating performance [1]. - The total amount for foreign exchange derivative trading by the company and its subsidiaries will not exceed 400 million yuan (or equivalent foreign currency) [1]. - The trading amount at any point during the effective period (including reinvested amounts) will not exceed the authorized limit, and funds can be recycled [1]. Group 2: Trading Methods and Counterparties - The trading methods will mainly include forward foreign exchange contracts, foreign exchange swaps, currency swaps, and foreign exchange options [1]. - The currencies involved will primarily be those used for overseas business settlements, mainly the US dollar [1]. - The trading counterparties will be qualified banks and financial institutions, and there will be no involvement of related parties [1]. Group 3: Authorization and Funding - The authorization period for the trading is valid for 12 months from the date of approval by the shareholders' meeting [1]. - If a single transaction's duration exceeds the authorized period, the authorization will automatically extend until the transaction is terminated [1]. - The funding source for the trading will be the company's own funds, without involving raised funds or bank credit [1]. Group 4: Risk Management - The company has established a management system for foreign exchange derivative trading to control risks across various aspects, including operational principles, responsibilities, internal processes, risk reporting, and information disclosure [2]. - Measures such as careful review of contract terms, tracking market price changes, and strengthening internal supervision will be implemented simultaneously [2]. - The board's audit committee, board of directors, and supervisory board have all approved the proposal, deeming the business necessary and the risk control measures feasible, with no harm to shareholder interests [2].